TRENTON, N.J. — Federal prosecutors in New Jersey say a former executive for biopharmaceuticals company Bristol-Myers Squibb has admitted using his high-level position and access to nonpublic information to make about $310,000 from insider trades.
Robert Ramnarine pleaded guilty Monday to securities fraud. The 46-year-old East Brunswick resident faces up to 20 years in prison and a $5 million fine when he's sentenced in September.
Ramnarine worked at the New York City-based company from 1997 to August 2012, holding several high-level positions. He was involved in evaluating potential acquisition targets including publicly traded companies and was privy to inside company information concerning such transactions.
Authorities say he abused that knowledge in three planned corporate transactions and made illegal stock option trades.
The Bristol-Myers Squibb Co.'s products include Plavix, for preventing blood clots and strokes.
Helen Simonson is in Jane Austen mode with 'The Hazelbourne Ladies Motorcycle and Flying Club'
Yuen: This Minnesota-based preacher left the church and found God in the woods
Artists from Universal Music Group are heading back to TikTok as new licensing deal reached
Coming soon to Airbnb: Prince's once-derelict Purple Rain House in Minneapolis
